JENNA THOMAS: Open Payments
NPI 1144008509 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,785 in 82 payments from 15 companies in 2025. Trend: 2023 $165 · 2024 $1,575 · 2025 $1,785
Food & beverage: $1,763Consulting: $22
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $320 |
| Galderma Laboratories, L.P. | 8 | $279 |
| Regeneron Healthcare Solutions, Inc. | 14 | $268 |
| GlaxoSmithKline, LLC. | 16 | $215 |
| AstraZeneca Pharmaceuticals LP | 7 | $167 |
| Lilly USA, LLC | 4 | $92 |
| CSL Behring | 3 | $68 |
| Grifols USA, LLC | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| Optinose US, Inc. | 3 | $57 |
Products named: DUPIXENT, NEMLUVIO, NUCALA, EBGLYSS, FASENRA, Andembry, Xembify, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
